Loading insider details...
Latest Form 4 (Sep 10, 2026): Sale of 22,408 RXRX shares, $78.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 22,408 | $78.8K |
| Aug 18, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax Withholding | 80,498 | $254.4K |
| Jun 5, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 23,588 | $84.5K |
| May 19, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax Withholding | 62,701 | $190.6K |
| Mar 11, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 28,298 | $94.7K |
| Feb 20, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax Withholding | 14,280 | $49.8K |
| Feb 10, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 1,673,546 | n/a |
| Dec 29, 2025 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale | 124,403 | $548.6K |
| Nov 20, 2025 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax Withholding | 17,584 | $72.8K |
| Nov 6, 2025 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 84,925 | n/a |